Peak Bio, Inc. Liabilities, Fair Value Adjustment
Peak Bio, Inc. reported Liabilities, Fair Value Adjustment of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-08-06.
Discontinued › Notes › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:LiabilitiesFairValueAdjustment · last filed 2024-08-06
- Peak Bio, Inc. liabilities, fair value adjustment for the quarter ending 2023-12-31 was $0.00.
- Peak Bio, Inc. liabilities, fair value adjustment for the quarter ending 2023-09-30 was $0.00.
- Peak Bio, Inc. liabilities, fair value adjustment for the quarter ending 2022-12-31 was -$1.10M.
- Peak Bio, Inc. liabilities, fair value adjustment for the quarter ending 2022-09-30 was -$87.22K.
- Peak Bio, Inc. liabilities, fair value adjustment for fiscal 2023 was $0.00.
- Peak Bio, Inc. liabilities, fair value adjustment for fiscal 2022 was -$1.19M.
- Peak Bio, Inc. liabilities, fair value adjustment for fiscal 2021 was $0.00.
| Period end | Liabilities, Fair Value Adjustment 3 month | Liabilities, Fair Value Adjustment 6 month | Liabilities, Fair Value Adjustment 9 month | Liabilities, Fair Value Adjustment 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-06 | $0.00 derived: sum of 2 quarters · filed 2024-08-06 | $0.00 10-K · filed 2024-08-06 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-06-25 | $0.00 10-Q · filed 2024-06-25 | ||
| 2022-12-31 | -$1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-06 | -$1.19M derived: sum of 2 quarters · filed 2024-08-06 | -$1.19M 10-K · filed 2024-08-06 | |
| 2022-09-30 | -$87.22K 10-Q · filed 2024-06-25 | -$87.22K 10-Q · filed 2024-06-25 | ||
| 2021-12-31 | $0.00 10-K · filed 2023-06-29 |